Comparative study between global pharmaceutical company and public institution of production and innovation in health
Bibliographic Data
| ID | 5334609 |
|---|---|
| Authors | Kelly Cristina Rodrigues Da Rocha (0000-0002-7002-8741, Fundação Oswaldo Cruz), Carlos Augusto Grabois Gadelha (0000-0002-9148-8819, Fundação Oswaldo Cruz) |
| Year | 2023 |
| Volume | 47 |
| Issue | 138 |
| Pages | 393-403 |
| Publication date | 2023-09-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Saúde em Debate (JOURNAL) |
| Journal identifiers | ISSN: 0103-1104 • E-ISSN: 2358-2898 |
| Publisher | FapUNIFESP (SciELO) (PUBLISHER) |
| DOI | 10.1590/0103-1104202313802i |
| OpenAlex | W4386832223 |
| Language | EN |
| References cited | 9 |
The technological scenario in the field of health is an alarming fact, especially in the context caused by COVID-19. In this context, the Oswaldo Cruz Foundation, through the Bio-Manguinhos Unit, and the Butantan Institute were protagonists for universal access, dialoguing with international strategies. In the strategic discussion for Public Institutions of Production and Innovation in Health (IPPIS), the use of guidelines of the Technological Assessment in Health stands out as a way of paradigmatic change for the introduction of technologies in the Unified Health System (SUS) in line with the vision of future innovation in health in accordance with national demands. This article, methodologically developed through qualitative descriptive research, bibliographical, documentary and field work, sought to trace symmetries and asymmetries based on the experiences collected in a global pharmaceutical company and a public national reference institution in the field of technological incorporation in health. As a result, key points are explained for the technical and political strengthening of the Health Economic-Industrial Complex, through the organizational review of the IPPIS regarding innovation and management aspects, culminating in the promotion of improvements in the science, technology and innovation policy in response to the challenge of sustainability, effectiveness and access in the SUS
Business · Context (archaeology) · Health care · Health promotion · Health technology · Institution · Political science · Politics · Promotion (chess) · Public health · Public relations · Social science · Sociology · Sustainability · Work (physics) · Engineering · Health Systems, Economic Evaluations, Quality of Life · Medicine · Pharmaceutical Economics and Policy · Public Health in Brazil
| Highly cited | No |
|---|